Literature DB >> 3530751

Diagnosis of systemic candidiasis: application of co-counterimmunoelectrophoresis.

D Poulain, J Fruit, L Fournier, E Dei Cas, A Vernes.   

Abstract

The accuracy of co-counterimmunoelectrophoresis was compared with mycological and clinical data for different groups of inpatients. The specificity and sensitivity of this method ranged from 100 to 69%. The co-specific precipitin line was observed during systemic infections caused by most opportunistic Candida species. The variations in the line in successive serum samples provided a simple means of serological surveillance. The test also detected seroconversion. The gradual disappearance of the line reflected a favourable prognosis, whereas its abrupt disappearance indicated unfavourable prognosis and correlated with the appearance of detectable circulating antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530751     DOI: 10.1007/bf02075699

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  8 in total

1.  Why are clinical laboratory tests performed? When are they valid?

Authors:  A F Krieg; R Gambino; R S Galen
Journal:  JAMA       Date:  1975-07-07       Impact factor: 56.272

2.  Immunoblot analysis of the serological response in systemic candidosis.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

3.  Fungal infections in the immunocompromised host.

Authors:  T L Ray
Journal:  Med Clin North Am       Date:  1980-09       Impact factor: 5.456

4.  Diagnosis of systemic candidiasis: development of co-counterimmunoelectrophoresis.

Authors:  D Poulain; J M Pinon
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 5.  Antigenic variability of Candida albicans.

Authors:  D Poulain; V Hopwood; A Vernes
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

6.  Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis.

Authors:  J P Burnie; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients.

Authors:  F C Odds; E G Evans
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

8.  Latex agglutination test for detection of Candida antigen in patients with disseminated disease.

Authors:  L O Gentry; I D Wilkinson; A S Lea; M F Price
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

  8 in total
  7 in total

1.  Detection of Candida antigenuria in disseminated candidiasis by immunoblotting.

Authors:  R P Ferreira; B Yu; Y Niki; D Armstrong
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 2.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 3.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

Review 4.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids.

Authors:  M P Hayette; G Strecker; C Faille; D Dive; D Camus; D W Mackenzie; D Poulain
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

6.  Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis.

Authors:  P Herent; D Stynen; F Hernando; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Probable presence of beta(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14- to 18-kilodalton antigen.

Authors:  D Poulain; C Faille; C Delaunoy; P M Jacquinot; P A Trinel; D Camus
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.